Followers | 34 |
Posts | 2651 |
Boards Moderated | 0 |
Alias Born | 10/28/2013 |
Monday, August 11, 2014 10:58:24 AM
If the stats they state are accurate, then these results sound very good. But early pseudo-progressives would have great responses that could swing the mean positive much farther than poor response from the true early progressives swings it negative and I am not sure if the simple mean is the normal measure for PFS efficacy. I thought there was some downplaying of extreme good numbers. I don't remember the method used by the FDA. (is the median used? That would downplay the extreme positives if they are not at least half of the population. That sounds familiar.)
As for the belated concern about radiation damaging the immune system... this bodes well for immunotherapies down the road as it makes it more clear that the change from existing radiation and chemo to immunotherapies is going to be turbulent. Those old technologies, however good or bad, were not optimized or selected for use along with chemotherapies.
But what does this mean at this point? Why would this have not been part of early statistics, whether they knew the underlying mechanism or not? Was there no radiation in the early data? Or just not enough data points... and the 40% that the radiation damages did not happen to be properly represented in that small group for the early studies? Without that knowledge, this post revelation does not make sense to me.
I remain very hopeful for DCVax-Direct. And I believe that the ability to target tumors directly and to not have to do surgery is such a wonderful possibility that I do not want to be negative about the company here. DCVax-Direct is much more valuable than DCVax-L. And it is more beautiful if I may use that word. So while early data remains promising, I remain very positive on NWBO. But I am not sure that the positive news today about L is not somewhat of a spin. If so, just hope the SP hangs in there until news on Direct becomes a focus. But this might be a short term problem.
Flipper is the progression vs pseudoprogression expert on this message board... and he is very smart. He catches things that I miss, and he sees things very clearly. And he is quiet this morning. Perhaps he is on a hike!
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2024 09:24:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:01:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:01:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 09:06:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 02:42:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
FEATURED North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM